How Did The Pharma Export Market Emerge During The Pandemic
                     How Did The Pharma Export Market Emerge 
During The Pandemic?
Medicine export from India
• The Indian pharmaceutical industry has a long history of creating the best pharma
 exports in India at competitive prices. India is known as the “pharmacy of the world”. It is the 
third-largest producer of  harmaceuticals by volume and the fourteenth-largest producer by 
value.
•  
• Medicine export from India
• They are known to be the best as it is the world’s largest supplier of generic drugs, making up a 
sizeable portion of the generic vaccination supply globally. In terms of providing vaccinations like 
DPT, BCG, and measles, India leads the globe.
• Also, it has the most US FDA-approved pharma export in the USA. Access to reasonably priced 
HIV medications is one of the great accomplishments of the Indian pharmaceutical industry. 
• India is also one of the biggest international suppliers of inexpensive vaccinations and is highly 
known for the export of pharmaceutical products from India. Drug formulations and biologicals 
account for the majority of India’s pharmaceutical exports, or around 75% of the total. India is 
known for its ability to do research and come up with affordable solutions for many diseases. 
Understanding in Detail About the Rapidly Growing 
Export Pharma Industry in India!
• In total 5.92% of the worldwide market for medicines and medications is covered 
by the top pharma export companies in India. With a share of 73.31%, 
formulations, and biologics made up the majority of India’s exports. It is followed 
by bulk pharmaceuticals and drug intermediates.
• The value of the nation’s pharmaceutical exports in 2021–22 was US$ 24.62 billion, 
unchanged from the prior year. Exports increased by 18% year on year to US$24.4 
billion in 2020–21. 
• The pharma export companies in India have these five as their top export 
destinations the United States, South Africa, the United Kingdom, Russia, and 
Nigeria.  This strong result was made possible despite lockdowns, global supply 
chain interruptions, and muted manufacturing. India exported medications and 
pharmaceuticals worth US$ 2.4 billion in March 2022. A 23% increase from US$ 
1.97 billion in February 2022. 
The Pharma Export Companies in India have Stayed 
Strong and are Growing
• India was a crucial player in the Covid-19 epidemic and showed that it could 
continue to provide the globe with pharmaceuticals even in times of need. India 
has the most US food and drugs administration (USFDA)-compliant businesses with 
facilities outside of the USA. 
• Almost 85% of the 20 worldwide generic businesses are based in India. And more 
than 55% of its exports go to highly regulated regions. 
• The Backup and Initiatives Taken by the Indian Government
• The Indian government has established several programs to support the 
pharmaceutical sector. The Development of a Pharmaceutical Industry initiative, 
with a total financial investment of Rs. 500 crores (US$ 64.5 million). It focuses on 
enhancing the current infrastructural facilities.
• Pharmaceuticals, crucial key ingredients, medical equipment, bulk drug parks, and 
other industries have production-linked incentive (PLI) programs to support 
producers. The Indian government wants to boost output and investment in the 
country’s pharmaceutical industry through the PLI plan.
Actions Done to Enhance and Encourage the Exports
• The Pharmaceuticals Export Promotion Council of India serves as the nation’s central 
organization for export promotion. The following are significant initiatives for export 
promotion:
• Reducing reliance on API imports: To satisfy its needs for local production and formulation, 
India primarily relies on API imports. The value of India’s imports of API was $3.68 billion as of 
FY21. The government has introduced plans to establish three bulk drug parks, medical device 
parks, and product-linked incentives (PLI) to support the production of APIs domestically.
• The Effect of Covid-19 on the Pharma Companies
• The COVID-19 pandemic has had immediate effects on demand, regulations, research and 
development processes. And the move to telemedicine and telecommunication. As long-term 
effects of the COVID-19 virus on the pharmaceutical sector. It is possible to expect industry 
growth slowdown, approval delays, moving toward self-sufficiency in the drug company 
supply chain, and trend shifts in consumption of health-market products, together with an 
ethical issue.
• From both a global and local standpoint. The COVID-19 worldwide pandemic may have a 
variety of short- and long-term effects on the healthcare industry, particularly the 
pharmaceutical industry.
Contact Us
• MEDIWIN PHARMA
• Email  [email protected]
• Phone 79-26405517
• mediwinpharma.com/